EndoFEMM Pad Found to be Useful in Temporary Relief of Pelvic Pain 

The ERC is delighted to report summary findings of our recent product focus study of the EndoFEMM Heating Pad [http://www.endofemm.com (website is now accepting orders)], developed by a woman with Endometriosis and manufactured by Dablo Enterprises.

CLICK HERE to see the official EndoFEMM Flyer!!!

Through our product focus study of this unique item, it was determined that the EndoFEMM pad was “well-received and well-liked” by the majority of our test subjects, who suffer collectively from a combined total of 182.5 woman-years of Endometriosis. 

The EndoFEMM pad was found to provide temporary relief in the course of its use by most study participants, and maintained its warmth for an impressive duration as compared to products of a similar nature.  In particular, the EndoFEMM pad’s proprietary and unique “kickstand” feature was particularly well-liked and determined by users to make the product superior to competitor products.  It was also discovered that the EndoFEMM pad provided secondary use and relief; for example, as a hot or cold compress for the head and/or elsewhere on the body.

Based on the results of our study, the ERC has concluded that the EndoFEMM pad has significant potential to help many women and girls with Endometriosis, as well as others in the chronic pelvic pain community.  We expect that the EndoFEMM pad will be a viable option for the non-invasive, temporary pain relief of Endometriosis and related disorders as compared to traditional or other alternative products of a similar nature. 

While the ERC does not endorse or recommend any specific products, treatments, physicians or corporations, we are pleased to provide information about this product as a further resource for Endometriosis sufferers as a potential non-invasive, non-toxic temporary relief option.  For more information including how to obtain the pad, please refer directly to the EndoFEMM website at http://www.endofemm.com (website is now accepting orders).

For complete study results, please contact us.  The ERC has no financial or compensatory disclosures to report in association with the product focus study outlined above.